Castle Biosciences Inc
CSTL· Nasdaq
CSTLCastle Biosciences Inc
Filed Feb 28, 2024 · 10-K · 59 days after period end · 0001447362-24-000017
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020 |
|---|---|---|---|---|
| Revenue | $66.12M | $38.34M | $25.04M | $17.30M |
| Net Income | -$2.58M | -$20.62M | -$6.43M | -$4.89M |
| EPS Diluted | — | — |
Castle Biosciences Inc · CIK 1447362 · Engraved from SEC EDGAR
| — |
| -$0.23 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2023 · filed Feb 28, 2024 · 59 d after period end
